L

Labiana Health SA
MAD:LAB

Watchlist Manager
Labiana Health SA
MAD:LAB
Watchlist
Price: 4.7 EUR Market Closed
Market Cap: 33.9m EUR

Net Margin
Labiana Health SA

1.3%
Current
-2%
Average
4.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
1.3%
=
Net Income
904.4k
/
Revenue
70.4m

Net Margin Across Competitors

No Stocks Found

Labiana Health SA
Glance View

Market Cap
32.9m EUR
Industry
Pharmaceuticals

Labiana Health SA manufactures sterile and lyophilized dosage forms. The company is headquartered in Pozuelo De Alarcon, Madrid and currently employs 477 full-time employees. The company went IPO on 2022-06-24. The Firm, through its subsidiaries, is engaged in the development, manufacturing and marketing of animal and human medicines. The Company’s main activities are: Drug research and development (R&D), which includes galenic and analytical development; Drug manufacturing, which focuses on formulation development, formulation optimization, bacterial vaccine manufacturing, among others; Regulatory services, which carries out registration procedures for pharmaceutical products in world markets. The Company, through its subsidiaries, is present in Ecuador, Mexico, Serbia and Turkey.

LAB Intrinsic Value
13.16 EUR
Undervaluation 64%
Intrinsic Value
Price
L
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
1.3%
=
Net Income
904.4k
/
Revenue
70.4m
What is the Net Margin of Labiana Health SA?

Based on Labiana Health SA's most recent financial statements, the company has Net Margin of 1.3%.

Back to Top